Issued Patents All Time
Showing 26–50 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10980738 | Programmable pharmaceutical compositions for chrono drug release | Siva Ram Kiran Vaka, Paras Jariwala, Jaydeep Vaghashiya, Atsawin Thongsukmak, Dipen Desai +1 more | 2021-04-20 |
| 10960001 | Opioid agonist / antagonist combination dosage forms | Navnit H. Shah, Dipen Desai, Harpreet K. Sandhu, Siva Ram Kiran Vaka, Chanchal Patel +2 more | 2021-03-30 |
| 10952957 | Self-regulating osmotic gastroretentive drug delivery systems | Navnit H. Shah, Dipen Desai, Jaydeep Vaghashiya, Kanji Meghpara | 2021-03-23 |
| 10925833 | Extended release compositions comprising pyridostigmine | Namdev B. Shelke, Siva Ram Kiran Vaka, Dipen Desai, Navnit H. Shah | 2021-02-23 |
| 10918597 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Harpreet K. Sandhu, Ashish Chatterji, Navnit H. Shah, Dipen Desai +1 more | 2021-02-16 |
| 10898431 | Programmable pharmaceutical compositions for chrono drug release | Siva Ram Kiran Vaka, Paras Jariwala, Jaydeep Vaghashiya, Atsawin Thongsukmak, Dipen Desai +1 more | 2021-01-26 |
| 10898430 | Self-regulating osmotic gastroretentive drug delivery systems | Navnit H. Shah, Dipen Desai, Jaydeep Vaghashiya, Kanji Meghpara | 2021-01-26 |
| 10881617 | Extended release compositions comprising pyridostigmine | Siva Ram Kiran Vaka, Namdev B. Shelke, Dipen Desai, Navnit H. Shah | 2021-01-05 |
| 10869839 | Extended release compositions comprising trihexyphenidyl | Namdev B. Shelke, Siva Ram Kiran Vaka, Navnit H. Shah, Dipen Desai | 2020-12-22 |
| 10857098 | Gastroretentive dosage forms for sustained drug delivery | Kanji Meghpara, Jaydeep Vaghashiya, Navnit H. Shah, Dipen Desai, Harpreet K. Sandhu +3 more | 2020-12-08 |
| 10849846 | Self-regulating osmotic gastroretentive drug delivery systems | Navnit H. Shah, Dipen Desai, Jaydeep Vaghashiya, Kanji Meghpara | 2020-12-01 |
| 10744131 | Abuse-resistant drug formulations | Harpreet K. Sandhu, Siva Ram Kiran Vaka, Ashish Chatterji, Dipen Desai, Navnit H. Shah | 2020-08-18 |
| 10744083 | Self-regulating osmotic gastroretentive drug delivery systems | Navnit H. Shah, Dipen Desai, Jaydeep Vaghashiya, Kanji Meghpara | 2020-08-18 |
| 10744093 | Extended release compositions comprising pyridostigmine | Siva Ram Kiran Vaka, Namdev B. Shelke, Dipen Desai, Navnit H. Shah | 2020-08-18 |
| 10632113 | Abuse-resistant drug formulations with built-in overdose protection | Siva Ram Kiran Vaka, Ashish Chatterji, Dipen Desai, Navnit H. Shah, Atsawin Thongsukmak +1 more | 2020-04-28 |
| 10588863 | Extended release compositions comprising pyridostigmine | Siva Ram Kiran Vaka, Namdev B. Shelke, Dipen Desai, Navnit H. Shah | 2020-03-17 |
| 10500282 | Supersaturated stabilized nanoparticles for poorly soluble drugs | Dipen Desai, Anekant Jain, Atsawin Thongsukmak, Navnit H. Shah | 2019-12-10 |
| 10406234 | Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms | Siva Ram Kiran Vaka, Dipen Desai, Navnit H. Shah, Kanji Meghpara | 2019-09-10 |
| 10195150 | Orally disintegrating tablet formulation for enhanced bioavailability | Jelena Djordjevic, Murali Mohan Bommana, Navnit H. Shah, Christopher A. Pizzo | 2019-02-05 |
| 10034865 | Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof | Navnit H. Shah, Atsawin Thongsukmak, Jaydeep Vaghashiya, Dipen Desai | 2018-07-31 |
| 9511078 | Self-nanoemulsion of poorly soluble drugs | Dipen Desai, Siva Ram Kiran Vaka, Navnit H. Shah, Anekant Jain | 2016-12-06 |
| 9370492 | Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers | Hashim Ahmed, Lewis H. Bender, Martin Howard Infeld, Shingai Majuru, Navnit H. Shah +1 more | 2016-06-21 |
| 7795237 | Pharmaceutical composition and process | Hashim Ahmed, Thomas Vernon Alfredson, Kondamraj Birudaraj, Michael Thomas Brandl, Navnit H. Shah +1 more | 2010-09-14 |
| 7014866 | High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same | Martin Howard Infeld, Navnit H. Shah, Lin Zhang | 2006-03-21 |
| 6492530 | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability | Antonio A. Albano, Harpreet K. Sandhu, Navnit H. Shah | 2002-12-10 |